title: [Chronic myeloid leukemia: comparison of monotherapy with busulfan with busulfan and vincristine and 6-mercaptopurine cycles].
authors.forename: F
authors.initials: F
authors.lastname: Cervantes
authors.forename: C
authors.initials: C
authors.lastname: Rozman
authors.forename: B
authors.initials: B
authors.lastname: Nomdedeu
authors.forename: J
authors.initials: J
authors.lastname: Blade
authors.forename: E
authors.initials: E
authors.lastname: Montserrat
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002066:Busulfan / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D015122:Mercaptopurine; D002066:Busulfan
vernacular_title: Leucemia mieloide crónica: comparación de la monoterapia con busulfán frente a busulfán y ciclos de vincristina y 6-mercaptopurina.